Mesa Labs Announces First Quarter Results
Globe Newswire (Mon, 10-Aug 4:01 PM ET)
Globe Newswire (Mon, 3-Aug 8:00 AM ET)
MESA LABS DECLARES QUARTERLY DIVIDEND
Globe Newswire (Mon, 6-Jul 9:50 AM ET)
Upcoming Q3 Results Could Shift Outlook for MLAB—What to Watch Ahead of February 3 Announcement
Market Chameleon (Thu, 4-Dec 5:45 AM ET)
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Mesa Laboratories trades on the NASDAQ stock market under the symbol MLAB.
As of September 2, 2026, MLAB stock price climbed to $130.65 with 137,665 million shares trading.
MLAB has a beta of 1.13, meaning it tends to be more sensitive to market movements. MLAB has a correlation of 0.06 to the broad based SPY ETF.
MLAB has a market cap of $731.10 million. This is considered a Small Cap stock.
Last quarter Mesa Laboratories reported $60 million in Revenue and $2.68 earnings per share. This fell short of revenue expectation by $-728,670 and exceeded earnings estimates by $.28.
In the last 3 years, MLAB traded as high as $155.12 and as low as $55.45.
The top ETF exchange traded funds that MLAB belongs to (by Net Assets): IWM, VTI, FESM, IWO, VXF.
MLAB has outperformed the market in the last year with a price return of +93.8% while the SPY ETF gained +19.8%. MLAB has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +24.3% and +21.2%, respectively, while the SPY returned +1.1% and -0.3%, respectively.
MLAB support price is $121.19 and resistance is $129.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MLAB shares will trade within this expected range on the day.